|
US2013022569A1
|
|
Hydrogels
|
|
US2014030341A1
|
|
Polymers and methods for the treatment of pain
|
|
US2012225926A1
|
|
Amphiphilic macromolecules for nucleic acid delivery
|
|
US2012219598A1
|
|
Polymeric micelles for reducing ldl in vivo
|
|
US2012058155A1
|
|
Slow-degrading polymers comprising salicylic acid for undelayed and sustained drug delivery
|
|
US2011229416A1
|
|
Amphiphilic macromolecules for solubilizing nanocrystals
|
|
US2012039983A1
|
|
Amphiphilic macromolecule-lipid complexes
|
|
US2010291180A1
|
|
Nerve guidance tubes
|
|
US2007014832A1
|
|
Therapeutic compositions and methods
|
|
US2009035248A1
|
|
Fast degrading polymers
|
|
US2005249697A1
|
|
Compositions and methods for the inhibition of bone growth and resorption
|
|
WO0209768A2
|
|
Therapeutic polyesters and polyamides
|
|
WO0209769A2
|
|
Therapeutic azo-compounds for drug delivery
|
